Interventional device developer Boston Scientific has received clearance from the Japanese Ministry of Health, Labour, and Welfare to market its Taxus Liberté paclitaxel-eluting coronary stent system.
The Natick, MA-based vendor said it would launch the system in Japan as soon as it receives the expected reimbursement approval in coming weeks.
Related Reading
Boston Scientific, Medtronic bury the hatchet, January 28, 2009
Boston Scientific wins FDA nod for small-vessel stent, September 25, 2008
Boston Scientific sells off investment portfolio to raise cash, June 19, 2008
Boston Scientific wins FDA clearance for heart failure lead, May 19, 2008
Boston Scientific launches Latitude analysis program, May 16, 2008
Copyright © 2009 AuntMinnie.com